News
08-24-2011, 04:14 AM
Amid the controversy surrounding the Food and Drug Administration's ruling that Avastin should no longer be used to treat metastatic breast cancer, a new multinational Phase III clinical trial shows that Avastin significantly increased tumor response rates in breast cancer patients when given before surgery...
More... (http://www.medicalnewstoday.com/releases/233248.php)
More... (http://www.medicalnewstoday.com/releases/233248.php)